Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.74 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.74 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.74 |
| ▸ | HTR2B | P41595 | 1/20 | 0.74 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.74 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.74 |
| ▸ | PTPN11 | Q06124 | 6/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.60 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL342176 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL2044840 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL18140779 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL18141371 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL3665313 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL1274781 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL527254 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL6575990 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL168816 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 | |
| SCHEMBL112985 | 1.00 | KMT2A (0.74) | KMT2AMEN1LMNACYP3A4NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240099976-A1 | BLENDED FORMULATIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2024-03-28 | — | — | US | claimed |
| CN-115851337-B | Preparation method of alkaline calcium alkyl salicylate | 新乡市瑞丰新材料股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-117050034-A | Multifunctional benzothiadiazole Schiff base luminescent liquid crystal and preparation and application thereof | 云南大学 | 2023-11-14 | — | — | CN | claimed |
| CN-115851337-A | Preparation method of alkaline calcium alkyl salicylate | 新乡市瑞丰新材料股份有限公司 | 2023-03-28 | — | — | CN | claimed |
| EP-3954361-A1 | MULTIPHASIC COMPOSITIONS | Sequessome Technology Holdings Limited (MT) | 2022-02-16 | — | — | EP | claimed |
| CN-112370377-A | High-protection waterproof sunscreen cream and preparation method thereof | 广州美莱洁化妆品开发有限公司 | 2021-02-19 | — | — | CN | claimed |
| US-20210007989-A1 | MULTIPHASIC COMPOSITIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2021-01-14 | — | — | US | claimed |
| US-20190167588-A1 | BLENDED FORMULATIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2019-06-06 | — | — | US | claimed |
| US-20180311148-A1 | MULTIPHASIC COMPOSITIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2018-11-01 | — | — | US | claimed |
| EP-3316856-A1 | BLENDED FORMULATIONS | Sequessome Technology Holdings Limited (MT) | 2018-05-09 | — | — | EP | claimed |
| EP-3316857-A1 | MULTIPHASIC COMPOSITIONS | Sequessome Technology Holdings Limited (MT) | 2018-05-09 | — | — | EP | claimed |
| WO-2017001617-A1 | BLENDED FORMULATIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2017-01-05 | — | — | WO | claimed |
| WO-2017001625-A1 | MULTIPHASIC COMPOSITIONS | SEQUESSOME TECHNOLOGY HOLDINGS LIMITED (MT) | 2017-01-05 | — | — | WO | claimed |
| CN-101332157-B | Cysteine derivatives | AJINOMOTO KK | 2012-01-11 | — | — | CN | claimed |
| CN-100453531-C | Cysteine derivatives | AJINOMOTO KK (JP) | 2009-01-21 | — | — | CN | claimed |
| US-20260144736-A1 | Aqueous Polymer Emulsion for Cosmetic, Method for Producing Same, and Cosmetic | TOAGOSEI CO., LTD. (JP) | 2026-05-28 | — | — | US | disclosed |
| US-12582590-B2 | Transparent liquid composition and cosmetic containing said composition | SEIWA KASEI COMPANY, LIMITED (JP) | 2026-03-24 | — | — | US | disclosed |
| WO-1988009365-A1 | DIESEL FUEL COMPOSITION | EXXON CHEMICAL PATENTS, INC. (US) | 1988-12-01 | — | — | WO | disclosed |
| EP-0293192-A1 | Diesel fuel composition | EXXON CHEMICAL PATENTS INC. (US) | 1988-11-30 | — | — | EP | disclosed |
| EP-0239444-A1 | Ferroelectric liquid crystal, process for its manufacture and its use in a liquid-crystal mixture | THOMSON-CSF (FR) | 1987-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582590-B2 | Transparent liquid composition and cosmetic containing said composition | GK, CUTA, GHDC | KMT2A 3227/4885MEN1 1200/4885LMNA 266/4885 |
| US-20260144736-A1 | Aqueous Polymer Emulsion for Cosmetic, Method for Producing Same, and Cosmetic | MMAB, RARB, RXRB | KMT2A 1273/4885MEN1 772/4885LMNA 765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.